ALEXANDRIA, Va., June 25 -- United States Patent no. 12,338,199, issued on June 24, was assigned to REGENERON PHARMACEUTICALS INC. (Tarrytown, N.Y.).
"Bis-octahydrophenanthrene carboxamides and protein conjugates thereof" was invented by Amy Han (Hockessin, Del.), Andrew J. Murphy (Croton-on-Hudson, N.Y.) and William Olson (Yorktown Heights, N.Y.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are compounds, compositions and methods for the treatment of diseases and disorders associated with the liver X receptor, including bis-octahydrophenanthrene carboxamides and protein (e.g., antibody) drug conjugates thereof."
The patent was filed on Oct. 5, 2021, under Application No. 17/494,762.
*For ...